ALK Rearrangement Adenocarcinoma with Histological Transformation to Squamous Cell Carcinoma Resistant to Alectinib and Ceritinib

Specific tyrosine-kinase inhibitors (TKIs) are widely used for the treatment of non-small-cell lung cancers with anaplastic lymphoma kinase (ALK) translocations. However, most treated patients eventually develop resistance to the TKIs. The histological transformation into small cell carcinoma is wel...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Onco Targets Ther
Huvudupphovsmän: Kaiho, Taisuke, Nakajima, Takahiro, Iwasawa, Shunichiro, Yonemori, Yoko, Yoshino, Ichiro
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove 2020
Ämnen:
Case Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7039243/
https://ncbi.nlm.nih.gov/pubmed/32110052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S236706
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk